Viral delivery systems for gene therapy

Understanding Gene Therapy

Volumn , Issue , 2023, Pages 21-42

  Murphy, Stephen J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85161143393     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781003423805-3     Document Type: Chapter

References (78)

1. Boris-Lawrie, K. and Temin, H.M. (1994) The retroviral vector-replication cycle and safety considerations for re tro virus-mediated gene-therapy. Ann. New York Acad. Sci., 716, 59-71.
2. Morgenstern, J.P. and Land, H. (1991) Choice and manipulation of retroviral vectors. In: Methods in Molecular Biology, Vol. 7, Gene Transfer and Expression Protocols (ed. E.J. Murray). The Human Press Inc., Clifton, NJ, pp. 181-205.
3. Coffin, J.M. (1996) Retroviridae: the viruses and their replication. In: Fundamental Virology, 3rd Edn (eds B.N. Field and D.M. Knipe), Raven Press, New York, pp. 771-813.
4. Wong-Staal, F. (1991) Human immunodeficiency viruses and their replication. Fundamental Virology, 2nd Edn (eds B.N. Fields and D.M. Knipe). Raven Press, New York, pp. 709-723.
5. Vile, R. (1991) The retroviral life cycle and the molecular construction of retroviral vectors. In: Methods in Molecular Biology, Vol. 8: Practical Molecular Virology: Viral Vectors for Gene Expression, (ed. M. Collins). The Humana Press, Inc., Clifton, NJ, pp. 1-15.
6. Miller, A.D. (1990) Retroviral packaging cells. Hum. Gene Ther., 1, 5-14.
7. Miller, A.D. Bender, M.A., Harris, E.A.S., Kaleko, M. and Gelinas, R.E. (1988) Design of retrovirus vectors for gene transfer and expression of the human B-globin gene. J. Virol., 62, 4337-4345.
8. Cosset, F.-L. and Russell, S.J. (1996) Targeting retrovirus entry. Gene Therapy, 3, 946-956.
9. Miller, D.B., Adam, M.A. and Miller, A.D. (1990) Gene transfer by retrovirus vectors occurs only in Cells that are actively replicating at the time of infection. Mol. Cell Biol. 10, 4239-4242.
10. Welsh, R.M., Cooper, N.R., Jensen, F.C. and Oldstone, M.B.A. (1975) Human serum lyses RNA tumour viruses. Nature, 257, 612-614.
11. Cossett, F.-L., Takeuchi, Y., Battini, J.-L., Weiss, R.A. and Collins, M.K.L. (1995) High titre packaging cells producing recombinant retroviruses resistent to human complement. J. Virol., 69, 7430-7436.
12. Takeuchi, Y., Cosset, F.L.C., Lachmann, P.J., Okada, H., Weiss, R.A. and Collins, M.K.L (1994) Type-c retrovirus inactivation by human-complement is determined by both the viral genome and the producer cell. J. Virol., 68, 8001-8007.
13. Salvatori, G., Ferrari, G., Mezzogiorno, A., Servidei, S., Coletta, M., Tonali, P., Giavazzi, R., Cossu, G. and Mavilio, F. (1993) Retroviral vector-mediated gene transfer into human primary myogenic Cells leads to expression in muscle fibres in vivo. Hum. Gene Ther., 4, 713-722.
14. Fassati, A., Wells, D.J., Walsh, F.S. and Dickson, G. (1996) Transplantation of retroviral producer Cells for in-vivo gene-transfer into mouse skeletalmuscle. Hum. Gene Ther., 7, 595-602.
15. Jahner, D., Stuhlmann, H., Stewart, C.L., Harbers, K., Lohler, J., Simon, I. and Jaenisch, R. (1982) Denovo methylation and expression of retroviral genomes during mouse embryogenesis. Nature, 298, 623-628.
16. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. and Trono, D. (1997) Multiply attenuated lenti viral vector achieves efficient gene delivery in vivo. Nat. Biotech., 15, 871-875.
17. Johnston, J. and Power, C. (1999) Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: Implications for vector development. Virol, 73, 2491-2498.
18. Delviks, K.A., Hu, W.U. and Pathak, V.K. (1997) Psi(-) vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J. Virol, 71, 6218-6224.
19. Olson, P., Temin, N.M. and Dornburg, A. (1992) Unusually high frequency of recombination of LTRs in U3-minus retrovirus vectors by DNA recombination or gene conversion. J. Virol, 66, 1336-1343.
20. Zhang, W.W. (1997) Review: Adenovirus vectors: development and application. Exp. O pin. Invest. Drugs, 6, 1419-1457.
21. Horwitz, M.S. (1990) Adenoviridae and their replication. In: Fundamental Virology, 2nd Edn (eds B.N. Field, D.M. Knipe and R.M. Channock). Raven Press, New York, pp. 1679-1740.
22. Shenk, T. (1996) Adenoviridae: the viruses and their replication. In Fields Virology, Vol. 2, 3rd Edn (eds B.N. Fields, D.M. Knipe and P.M. Howley). Lippincott-Raven, Philadelphia, PA, pp. 2111-2148.
23. Norrby, E. (1969) The structural and functional diversity of Adenovirus capsid components. J. Gen. Virol, 5, 221-236.
24. Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurtjones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L. and Finberg, R.W. (1997) Isolation of a common receptor for Coxsackie b viruses and adenoviruses 2 and 5. Science, 275, 1320-1323.
25. Davidson, E., Diaz, R.M., Hart, I., Santis, G. and Marshall, J.F. (1997) Integrin A5B1 -mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16. J. Virol, 71, 6204-6207.
26. Grabie, M. and Hearing, P. (1992) Cis and trans requirements for the selective packaging of adenovirus type-5 DNA. J. Virol, 66, 723-731.
27. Bett, A.J., Prevec, L. and Graham, F.L. (1993) Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol, 67, 5911-5921.
28. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characterisation of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol, 36, 59-74.
29. Bett, A.J., Haddara, W., Prevec, L. and Graham, F.L. (1994) An efficient and flexible system for construction of adenovirus vectors with inserts or deletions in early regions 1 and 3. Proc. Natl Acad. Sci. USA, 91, 8802-8806.
30. Berkner, K. L. (1988) Development of adenovirus vectors for the expression of heterologous genes. BioTechniques, 6, 616-629.
31. Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D.H., Alvira, M., Buttrick, P.M. and Leiwand, L.A. (1994) The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther., 1, 395-402.
32. Rosenfeld, M.A., Siegfried, W., Yoshimura, K. et al. (1991). Adenovirus-mediated transfer of a recombinant A1-antitrypsin gene to the lung epithelium in vivo. Science, 252, 431-434.
33. Horwitz (1990) Adenoviruses. In: Fundamental Virology, 2nd Edn (ed. B.N. Field, D.M. Knipe and R.M. Channock). Raven Press, New York, pp. 1723-1740.
34. Yang, Y., Nunes, F.A., Berencsi, K., Gonczol, E., Engelhardt, J.F. and Wilson, J.M. (1994) Inactivation of E2A in recombinant adenoviruses improves the prospect for gene-therapy in cystic-fibrosis. Nat. Genet., 7, 362-369.
35. Grubb, B.R., Pickles, R.J., Ye, H., Yankaskas, J.R., Vick, Rn., Engelhardt, J.F., Wilson, J.M., Johnson, L.G. and Boucher, R.C. (1994) Inefficient gene-transfer by adenovirus vector to cystic-fibrosis airway epithelia of mice and humans. Nature, 371, 802-806.
36. Yang, Y., Jooss, K.U., Su, Q., Erti, H.C.J, and Wilson, J.M. (1996) Immune response to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther., 3, 137-144.
37. Ragot, T., Vincent, N., Chafey, P., Vigne, E., Gilgenkrantz, H., Couton, D., Cartaud, J., Briand, P., Kaplan, J.C., Perricaudet, M. and Kahn, A. (1993) Efficient adenovirus-mediated transfer of a human mini-dystrophin gene to skeletal muscle of mdx mice. Nature, 361, 647-650.
38. Yei, S., Mittereder, N., Te, K., O'Sullivan, C. and Trapnell, B.C. (1994) Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther, 1, 192-200.
39. Dong, J.-Y., Wang, D., Van Ginkel, F.W., Pascual, D.W. and Frizzell, R.A. (1996) Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum. Gene Ther., 7, 319-331.
40. Zhou, H.S., O'Neal, W., Morral, N. and Beaudet, A.L. (1996) Development of a complementing cell-line and a system for construction of adenovirus vectors with E1 and E2A deleted. J. Virol, 70, 7030-7038.
41. Gorziglia, M.I., Kadan, M.J., Yei, S., Lim, J., Lee, G.M., Luthra, R. and Trapnell, B.C. (1996) Elimination of both El and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol, 70, 4173-4178.
42. Wang, Q., Greenburg, G., Bunch, D., Farson, D. and Finer, M.H. (1997) Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector. Gene Ther., 4, 393-400.
43. Armentano, D., Zabner, J., Sacks, C, Sookdeo, CC, Smith, M.P., St. George, J.A., Wadsworth, S.C., Smith, A.E. and Gregory, R.J. (1997) Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol, 71, 2408-2416.
44. Beier, D.C., Cox, J.H., Vining, D.R., Cresswell, P. and Engelhard, V.H. (1994) Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol, 152, 3862-3872.
45. Dai, Y., Schwarz, E., Gu, D., Zhang, W., Sarvetnick, N. and Verma, I. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl Acad. Sci. USA, 92, 1401-1405.
46. Engelhardt, J.F., Ye, X., Doranz, B. and Wilson, J.M. (1994) Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl Acad. Sci. USA, 91, 6196-6200.
47. Lochmuller, H., Petrof, B.J., Pari, G. et al (1996) Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal-muscles of adult dystrophic (mdx) mice. Gene Ther., 3, 706-716.
48. Kaplan, J.M. and Smith, A.E. (1997) Transient immunosuppression with deoxyspergualin improves longevity of transgene expression and ability to readminister adenoviral vector to the mouse lung. Hum. Gene Ther., 8, 1095-1104.
49. Kumar-Singh, R. and Chamberlain, J.S. (1996) Encapsidated adenovirus minichromosomes allow delivery and expression of a 14kb dystrophin cDNA to muscle cells. Hum. Mol. Genet., 5, 913-921.
50. Chen, H.H., Mack, L.M., Kelly, R., Ontell, M., Kochanek, S. and Clemens, P.R. (1997) Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl Acad. Sci. USA, 94, 1645-1650.
51. Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, A. and Graham, F.L. (1996) A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl Acad. Sci. USA, 93, 13565-13570.
52. Haecker, S.E., Stedman, H., Balice-Gordan, R.J., Smith, D.B.J., Greelish, J.P., Mitchell, M.A., Wells, A., Sweeney, H.L. and Wilson, J.M. (1996) In vivo expression of full-length dystrophin from adenoviral vectors deleted of all viral genes. Hum. Gene Ther., 7, 1907-1914.
53. Murphy, S.J., Bell, S.J., Chong, H., Diaz, R.M. and Vile, R.G. (1998) Adenovirus-mediated delivery of an excisable retroviral cassette which can stable integrate into target cell genomes. J. Gene Med., 1, Suppl. 74, Abstract.
54. Parks, R.J. and Graham, F.L. (1997) A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging. J. Virol, 71, 3293-3298.
55. Wickham, T.J., Carrion, M.E. and Kovesdi, I. (1995) Targeting of adenovirus penton to new receptors through replacement of its RGD motif with other receptor specific peptide motifs. Gene Ther., 2, 750-756.
56. Kransnykh, V., Dmitriev, I., Mikheeva, G., Miller, C.R., Belousova, N. and Curiel, D.T. (1998) Characterisation of an adenovirus vector containing a heterologous peptide epitope in the H1 loop of the fibre knob. J. Virol, 72, 1844-1852.
57. Monahan, P.E., Samulski, R.J., Tazelaar, J., Xiao, X., Nicholas, T.C., Bellinger, D.A., Read, M.S. and Walsh, C.E. (1998) Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of haemophilia. Gene Ther., 5, 40-49.
58. Kremer, E.J. and Perricaudet, M. (1995) Adenovirus and adenoassociated virus-mediated gene-transfer. British Med. Bull, 51, 31-44.
59. Muzyczka, N. (1992) Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol, 158, 97-129.
60. Verma, I.M. and Somia, N. (1997) Gene therapy-promises, problems and prospects. Nature, 389, 239-242.
61. Bordignon, C, Notarangelo, L.D., Nobili, N. et al (1995) Gene therapy in peripheral-blood lymphocytes and bone-marrow for ADA(-) immunodeficient patients. Science, 270, 470-475.
62. Efstathiou, S. and Minson, A.C. (1995) Herpes virus-based vectors. Brit. Med. Bull, 51, 45-55.
63. Huard, J., Krisky, D., Oligino, T., Marconi, P., Day, C.S., Watkins, S.C. and Glorioso, J.C. (1997) Gene transfer to muscle using herpes simplex virus-based vectors. Neuromusc. Disord., 7, 299-313.
64. Hermens, W.T. and Verhaagen, J. (1998) Viral vectors, tools for gene transfer in the nervous system. Progress Neurobiol, 55, 399-432.
65. Brehm, M, Samaniego, L.A., Bonneau, R.H., DeLuca, N.A. and Tevethia, S.S. (1999) Immunogenicity if herpes simplex virus type 1 mutants containing deletions in one or more of the oc-genes: ICP4, ICP27, ICP22, and ICP0. Virology, 256, 258-269.
66. Frenkel, N., Singer, O. and Kwong, A.D. (1994) Minireview: The herpes simplex virus amplicon-a versatile defective virus vecto. Gene Ther., 1, S40-S46.
67. Ponnazhagan, S., Weigel, K.A., Raikwar, S.P., Mukherjee, P., Yoder, M.C. and Srivastava, A. (1998) Recombinant human parvovirus B19 vectors: erythroid cell-specific delivery and expression of transduced genes. J. Virol., 72, 5224-5230.
68. Srivastava, A., Wang, X.S., Ponnazhagan, S., Zhou, S.Z. and Yoder, M.C. (1996) Adeno-associated virus 2-mediated transduction and erythroid lineage-specific expression in human hematopoietic progenitor cells. Curr. Top. Microb. Immun., 218, 93-117.
69. Fisher, K.J., Choi, H., Burda, J., Chen, S.J. and Wilson, J.M. (1996) Recombinant adenovirus deleted of all viral genes for gene-therapy of cysticfibrosis. Virology, 217, 11-22.
70. Johnston, K.M., Jacoby, D., Pechan, P.A., Fraefel, C, Borghesani, P., Schuback, D., Dunn, R.J., Smith, F.I. and Breakefield, X.O. (1997) HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
71. Fraefel, C, Jacoby, D.R., Lage, C, Hilderbrand, H., Chou, J.Y., Alt, F.W., Breakefield, X.O. and Majzoub, J.A. (1997) Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid. Mol. Med., 3, 813-825.
72. Palombo, F., Monciotti, A., Recchia, A., Cortese, R., Ciliberto, G. and La Monica, N. (1998) Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector. J. Virol. 72, 5025-5034.
73. Naldini, L., Blomer, U., Gage, F.H., Trono, D. and Verma, I.M. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. USA., 93, 11382-11388.
74. Gasmi, M., Glynn, J., Jin, M.J., Jolly, D.J., Yee, J.K. and Chen, S.T. (1999) Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J. Virol. 73, 1828-1834.
75. Feng, M., Jackson, W.H., Goldman, C.K., Rancourt, C, Wang, M., Dusing, S.K., Siegal, G. and Curiel, D.T. (1997) Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector [see comments]. Nat. Biotech., 15, 866-870.
76. Holzer, G.W., Mayrhofer, J.A., Gritschenberger, W., Dorner, F. and Falkner, F.G. (1999) Pox viral/retro viral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles. Virology, 253, 107-114.
77. Wang, S. and Vos J.M. (1996) A hybrid herpesvirus infection vector based on Epstein-Barr virus and herpes simplex virus type I for gene transfer into human cells in vitro and in vivo. J. Virol., 70, 8422-8430.
78. Lewis, A.M. (1998) SV40 in adenovirus vaccines and adenovirus-SV40 recombinants. Dev. Biol. Stand, 94, 207-216.